English | Español

Bristol-Myers Squibb
Jamie Barrand | Feb 23, 2016

Bristol-Myers Squibb's hepatitis C study focuses on Asian populations
Jamie Barrand | Feb 18, 2016

Pharmaceutical partnership to focus on high-risk cancer research
Jamie Barrand | Feb 10, 2016

FDA expands label for Bristol-Myers Squibb's Daklinza therapy
Jamie Barrand | Feb 4, 2016

Pharmaceutical companies investigate anticoagulant agent to reduce strokes
Caitlin Nordahl | Jan 29, 2016

FDA expands approved use of Bristol-Myers Squibb’s late-stage melanoma treatment
Kasey Schefflin- Emrich | Jan 26, 2016

Bristol-Myers Squibb recognized for advancing multiple myeloma research
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb sells HIV therapy portfolio to ViiV Healthcare
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb gives $397,422 to help launch military transition project

Trending
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Regulatory
Patient Daily | Oct 14, 2025

Mackinac Center raises concerns over federal 340B drug pricing program’s market impact